ClinVar Miner

Submissions for variant NM_000441.2(SLC26A4):c.2153T>C (p.Phe718Ser)

gnomAD frequency: 0.00005  dbSNP: rs750834241
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000441837 SCV000521214 likely pathogenic not provided 2016-08-18 criteria provided, single submitter clinical testing The F718S variant in the SLC26A4 gene has been reported previously in association with hearing loss, in an individual who was heterozygous for the F718S and another variant (Sommen et al., 2016), and in individuals with were heterozygous for the F718S variant and no second variant identified (Mercer et al., 2011; Landa et al., 2013). The F718S variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The F718S variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position where amino acids with similar properties to Phenylalanine are tolerated across species. In silico analysis predicts this variant is probably damaging to the protein structure/function. Missense variants in nearby residues (R714K, K715N, D716G, T721M, H723Y, H723D, H723R) have been reported in the Human Gene Mutation Database in association with hearing loss (Stenson et al., 2014), supporting the functional importance of this region of the protein. The F718S variant is a strong candidate for a pathogenic variant, however the possibility it may be a rare benign variant cannot be excluded.
Myriad Genetics, Inc. RCV000984219 SCV002060351 uncertain significance Pendred syndrome 2021-10-01 criteria provided, single submitter clinical testing NM_000441.1(SLC26A4):c.2153T>C(F718S) is a missense variant classified as a variant of uncertain significance in the context of Pendred syndrome. F718S has been observed in cases with relevant disease (PMID: 27068579, 23965030, 21366435). Functional assessments of this variant are not available in the literature. F718S has been observed in population frequency databases (gnomAD: NFE 0.01%). In summary, there is insufficient evidence to classify NM_000441.1(SLC26A4):c.2153T>C(F718S) as pathogenic or benign. Please note: this variant was assessed in the context of healthy population screening.
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV002282143 SCV002571862 uncertain significance not specified 2022-08-08 criteria provided, single submitter clinical testing Variant summary: SLC26A4 c.2153T>C (p.Phe718Ser) results in a non-conservative amino acid change located in the STAS domain (IPR002645) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 3.2e-05 in 251316 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.2153T>C has been reported in the literature in one biallelic individual affected with Hearing Loss (Sommen_2016), and two monoallelic individuals with suspected Pendred Syndrome (Landa_2013, Mercer_2011). These data do not allow any conclusion about variant significance. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Three ClinVar submitters have assessed the variant since 2014: two classified the variant as of uncertain significance and one as likely pathogenic. Based on the evidence outlined above, the variant was classified as uncertain significance.
Invitae RCV000441837 SCV003294380 uncertain significance not provided 2021-08-13 criteria provided, single submitter clinical testing This sequence change replaces phenylalanine with serine at codon 718 of the SLC26A4 protein (p.Phe718Ser). The phenylalanine residue is highly conserved and there is a large physicochemical difference between phenylalanine and serine. This variant is present in population databases (rs750834241, ExAC 0.005%). This missense change has been observed in individual(s) with deafness with enlarged vestibular aqueduct (PMID: 21366435, 27068579). ClinVar contains an entry for this variant (Variation ID: 381687). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.